Search for other papers by M Axelstad in
Google Scholar
PubMed
Search for other papers by U Hass in
Google Scholar
PubMed
Search for other papers by M Scholze in
Google Scholar
PubMed
Search for other papers by S Christiansen in
Google Scholar
PubMed
Search for other papers by A Kortenkamp in
Google Scholar
PubMed
Search for other papers by J Boberg in
Google Scholar
PubMed
investigating how male reproduction may be influenced by developmental exposure of rats to the painkiller paracetamol or to mixtures of human relevant environmental EDCs. In addition to a therapeutically relevant dose of paracetamol, a mixture of 8 anti-androgenic
Search for other papers by Lachlan Angus in
Google Scholar
PubMed
Search for other papers by Shalem Leemaqz in
Google Scholar
PubMed
Search for other papers by Olivia Ooi in
Google Scholar
PubMed
Search for other papers by Pauline Cundill in
Google Scholar
PubMed
Search for other papers by Nicholas Silberstein in
Google Scholar
PubMed
Search for other papers by Peter Locke in
Google Scholar
PubMed
Search for other papers by Jeffrey D Zajac in
Google Scholar
PubMed
Search for other papers by Ada S Cheung in
Google Scholar
PubMed
differing mechanisms of action. Spironolactone is a mineralocorticoid receptor antagonist and is anti-androgenic in four ways. First, it is a peripheral androgen receptor partial antagonist (IC50 = 77 nmol/L) ( 10 ). The IC50, which is the concentration of
Search for other papers by Yen Kheng Tan in
Google Scholar
PubMed
Search for other papers by Yu Heng Kwan in
Google Scholar
PubMed
Search for other papers by David Choon Liang Teo in
Google Scholar
PubMed
Search for other papers by Marieke Velema in
Google Scholar
PubMed
Search for other papers by Jaap Deinum in
Google Scholar
PubMed
Search for other papers by Pei Ting Tan in
Google Scholar
PubMed
Search for other papers by Meifen Zhang in
Google Scholar
PubMed
Search for other papers by Joan Joo Ching Khoo in
Google Scholar
PubMed
Search for other papers by Wann Jia Loh in
Google Scholar
PubMed
Search for other papers by Linsey Gani in
Google Scholar
PubMed
Search for other papers by Thomas F J King in
Google Scholar
PubMed
Search for other papers by Eberta Jun Hui Tan in
Google Scholar
PubMed
Search for other papers by Shui Boon Soh in
Google Scholar
PubMed
Search for other papers by Vanessa Shu Chuan Au in
Google Scholar
PubMed
Search for other papers by Tunn Lin Tay in
Google Scholar
PubMed
Search for other papers by Lily Mae Quevedo Dacay in
Google Scholar
PubMed
Search for other papers by Keng Sin Ng in
Google Scholar
PubMed
Search for other papers by Kang Min Wong in
Google Scholar
PubMed
Search for other papers by Andrew Siang Yih Wong in
Google Scholar
PubMed
Search for other papers by Foo Cheong Ng in
Google Scholar
PubMed
Search for other papers by Tar Choon Aw in
Google Scholar
PubMed
Search for other papers by Yvonne Hui Bin Chan in
Google Scholar
PubMed
Search for other papers by Khim Leng Tong in
Google Scholar
PubMed
Search for other papers by Sheldon Shao Guang Lee in
Google Scholar
PubMed
Search for other papers by Siang Chew Chai in
Google Scholar
PubMed
Search for other papers by Troy Hai Kiat Puar in
Google Scholar
PubMed
anti-androgenic side effects of MR antagonists. Patient-perceived health outcomes have an increasingly important role in healthcare. One of the most widely used questionnaires is the RAND-36, a generic HRQoL questionnaire which captures multiple
Search for other papers by André Marques-Pinto in
Google Scholar
PubMed
Serviço de Endocrinologia, Departamento de Endocrinologia, Faculdade de Medicina da Universidade do Porto, Al. Prof. Hernâni Monteiro, 4200-319 Porto, Portugal
Search for other papers by Davide Carvalho in
Google Scholar
PubMed
oestrogenic/anti-androgenic activity that act by interfering with the oestrogen receptors (ER) or the androgen receptor (AR) (see Table 1 ). Table 1 Reported agonist and antagonist binding of several ED to ER and AR. ED ER agonism ER antagonism AR agonism AR
Search for other papers by Rachel Forfar in
Google Scholar
PubMed
Search for other papers by Mashal Hussain in
Google Scholar
PubMed
Search for other papers by Puneet Khurana in
Google Scholar
PubMed
Search for other papers by Jennifer Cook in
Google Scholar
PubMed
Search for other papers by Steve Lewis in
Google Scholar
PubMed
Search for other papers by Dillon Popat in
Google Scholar
PubMed
Search for other papers by David Jackson in
Google Scholar
PubMed
Search for other papers by Ed McIver in
Google Scholar
PubMed
Search for other papers by Jeff Jerman in
Google Scholar
PubMed
Search for other papers by Debra Taylor in
Google Scholar
PubMed
Search for other papers by Adrian JL Clark in
Google Scholar
PubMed
Search for other papers by Li F Chan in
Google Scholar
PubMed
and Cellular Endocrinology 2014 394 99 – 104 . ( https://doi.org/10.1016/j.mce.2014.07.003 ) 11 Parween S Rihs S Fluck CE . Metformin inhibits the activation of melanocortin receptors 2 and 3 in vitro: a possible mechanism for its anti-androgenic
Search for other papers by Lina S Silva-Bermudez in
Google Scholar
PubMed
Search for other papers by Freddy J K Toloza in
Google Scholar
PubMed
Search for other papers by Maria C Perez-Matos in
Google Scholar
PubMed
Search for other papers by Russell J de Souza in
Google Scholar
PubMed
Search for other papers by Laura Banfield in
Google Scholar
PubMed
Search for other papers by Andrea Vargas-Villanueva in
Google Scholar
PubMed
Search for other papers by Carlos O Mendivil in
Google Scholar
PubMed
and dienogest are considered anti-androgenic ( 3 ). Given that available studies have used combined OC with distinct combinations and doses of estrogen and progestin, using a wide variety of comparators, the overall impact of each OC on metabolic
Search for other papers by Elizabeth Micks in
Google Scholar
PubMed
Search for other papers by Greta B Raglan in
Google Scholar
PubMed
Department of Obstetrics and Gynecology, Department of Research, University of Washington, Box 356460, 1959 NE Pacific Street, Seattle, Washington, USA
Search for other papers by Jay Schulkin in
Google Scholar
PubMed
cyproterone acetate, have anti-androgenic and anti-mineralocorticoid activity, possibly leading to desirable non-contraceptive benefits in certain patients (65) . Most data regarding the differences between different progestins are from in vitro biochemical
Imperial College London, London, UK
Search for other papers by D A Dart in
Google Scholar
PubMed
Search for other papers by K Ashelford in
Google Scholar
PubMed
Search for other papers by W G Jiang in
Google Scholar
PubMed
. Novel trifluoromethylated Enobosarm analogues with potent anti-androgenic activity in vitro and tissue selectivity in vivo . Molecular Cancer Therapeutics 2018 17 1846 – 1858 . ( https://doi.org/10.1158/1535-7163.MCT-18-0037 ) 11 Koushyar S
Search for other papers by Frederic Schrøder Arendrup in
Google Scholar
PubMed
Search for other papers by Severine Mazaud-Guittot in
Google Scholar
PubMed
EHESP-School of Public Health, Rennes, France
Search for other papers by Bernard Jégou in
Google Scholar
PubMed
Inserm (Institut National de la Santé et de la Recherche Médicale), Irset – Inserm, UMR 1085, Rennes, France
Search for other papers by David Møbjerg Kristensen in
Google Scholar
PubMed
exposure resulted in decreased anogenital distance index (AGDi) among the female offspring. Prenatal APAP has previously been associated with decreased male AGDi in both experimental rodent models and humans ( 8 , 14 , 37 , 38 ), attributed to anti-androgenic
Search for other papers by Karim Gariani in
Google Scholar
PubMed
Diabetes Center, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Search for other papers by François R Jornayvaz in
Google Scholar
PubMed
PCOS with NAFLD, in order to notably establish whether treatment with anti-androgenic drugs may reduce the risk of NAFLD in women with PCOS. Hypothyroidism Hypothyroidism is a frequent endocrine disorder defined by thyroid hormone insufficiency